Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia

BACKGROUND: Group 3 pulmonary hypertension (PH) encompasses PH owing to lung diseases and/or hypoxia. Treatment patterns, healthcare resource use, and economic burden to US payers of Group 3 PH patients were assessed. METHODS: This retrospective observational study extracted data from July 1, 2010 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Heresi, Gustavo A., Platt, David M., Wang, Wenyi, Divers, Christine H., Joish, Vijay N., Teal, Simon A., Yu, Justin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387228/
https://www.ncbi.nlm.nih.gov/pubmed/28399914
http://dx.doi.org/10.1186/s12890-017-0399-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387228/
https://www.ncbi.nlm.nih.gov/pubmed/28399914
http://dx.doi.org/10.1186/s12890-017-0399-1

Ejemplares similares